Certified
« back to search results

TAW-81385  /  Pfizer Therapeutic Research (Groton, CT)

Petitioner Type: State
Impact Date: 02/27/2011
Filed Date: 03/02/2012
Most Recent Update: 06/13/2012
Determination Date: 06/13/2012
Expiration Date: 06/13/2014

DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-81,385

PFIZER THERAPEUTIC RESEARCH
PFIZER WORLDWIDE REASEARCH & DEVELOPMENT DIVISION
FORMERLY KNOWN AS WARNER LAMBERT COMPANY
CENTRAL NERVOUS SYSTEM RESEARCH UNIT
GLOBAL EXTERNAL SUPPLY DEPARTMENT
PHARMACEUTICAL DEVELOPMENT DEPARTMENT
GROTON, CONNECTICUT

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974,
as amended ("Act"), 19 U.S.C. § 2273, the Department of Labor
herein presents the results of an investigation regarding
certification of eligibility to apply for worker adjustment
assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the
workers in such workers' firm have become totally or
partially separated, or are threatened to become
totally or partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of
articles or supply of services like or directly
competitive with those produced/supplied by the
workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have
contributed importantly to the workers'
separation or threat of separation.

The investigation was initiated in response to a petition
filed on March 2, 2012 by the Connecticut State Workforce
Office on behalf of workers of Pfizer Therapeutic Research,
Pfizer Worldwide Research & Development Division, formerly
known as Warner Lambert Company, Central Nervous System
Research Unit, Global External Supply Department,
Pharmaceutical Development Department, Groton, Connecticut.
The aforementioned groups supply pharmaceutical and scientific
research services for pharmaceutical development.
During the course of the investigation, information was
collected from the petitioning state workforce office, the
separated workers and the workers' firm.
Section 222(a)(1) has been met because a significant
number or proportion of the workers in such workers' firm have
become totally or partially separated, or are threatened to
become totally or partially separated.
Section 222(a)(2)(B) has been met because the workers'
firm has shifted to a foreign country the supply of services
like or directly competitive with the pharmaceutical and
scientific research services supplied by the workers which
contributed importantly to worker group separations in the
Groton, Connecticut facility.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Pfizer Therapeutic
Research, Pfizer Worldwide Research & Development Division,
formerly known as Warner Lambert Company, Central Nervous
System Research Unit, Global External Supply Department,
Pharmaceutical Development Department, Groton, Connecticut,
who are engaged in activities related to the supply of
pharmaceutical and scientific research services meet the
worker group certification criteria under Section 222(a) of
the Act, 19 U.S.C. § 2272(a). In accordance with Section 223
of the Act, 19 U.S.C. § 2273, I make the following
certification:


"All workers of Pfizer Therapeutic Research, Pfizer
Worldwide Research & Development Division, formerly known
as Warner Lambert Company, Central Nervous System
Research Unit, Global External Supply Department,
Pharmaceutical Development Department, Groton,
Connecticut, who became totally or partially separated
from employment on or after February 27, 2011 through two
years from the date of certification, and all workers in
the group threatened with total or partial separation
from employment on the date of certification through two
years from the date of certification, are eligible to
apply for adjustment assistance under Chapter 2 of Title
II of the Trade Act of 1974, as amended."
Signed in Washington, D.C., this 13th day of June, 2012.


/s/Michael W. Jaffe
______________________________
MICHEAL W. JAFFE
Certifying Officer, Office of
Trade Adjustment Assistance